Loading...

LivaNova PLC

LIVNNASDAQ
Healthcare
Medical - Devices
$43.46
$-0.21(-0.48%)

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.3/100

Key Financials

Market Cap2.4B
P/E Ratio-10.71
EPS (TTM)$-4.07
ROE-0.18%
Fundamental Analysis

AI Price Forecasts

1 Week$44.70
1 Month$45.93
3 Months$39.13
1 Year Target$51.50

LIVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LivaNova PLC (LIVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $51.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.71 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;